TSANTES, Elena
 Distribuzione geografica
Continente #
NA - Nord America 187
EU - Europa 155
AS - Asia 91
Totale 433
Nazione #
US - Stati Uniti d'America 186
IE - Irlanda 62
SG - Singapore 39
CN - Cina 36
SE - Svezia 31
DE - Germania 16
IT - Italia 14
GB - Regno Unito 12
FI - Finlandia 8
UA - Ucraina 8
IN - India 7
HK - Hong Kong 4
CH - Svizzera 2
JP - Giappone 2
VN - Vietnam 2
CA - Canada 1
CZ - Repubblica Ceca 1
NL - Olanda 1
TR - Turchia 1
Totale 433
Città #
Dublin 62
Chandler 32
Singapore 31
Ashburn 20
Santa Clara 12
Shanghai 12
Boardman 11
Princeton 11
Wilmington 9
Helsinki 8
Des Moines 7
Beijing 6
Munich 6
Como 4
Hong Kong 4
Nanjing 4
Woodbridge 4
Ann Arbor 3
Borås 3
Fairfield 3
Dong Ket 2
Hebei 2
Milan 2
Motomachi 2
New York 2
Padova 2
Redwood City 2
Reggio Emilia 2
Tianjin 2
Augusta 1
Brno 1
Bursa 1
Camerano 1
Council Bluffs 1
Dallas 1
Falls Church 1
Fremont 1
Grafing 1
Haikou 1
Houston 1
Jinan 1
Karlsruhe 1
Lanzhou 1
London 1
Mountain View 1
Nanchang 1
Ningbo 1
Norwalk 1
Rockville 1
San Mateo 1
Seattle 1
Secaucus 1
Shenzhen 1
Taizhou 1
Toronto 1
Zhengzhou 1
Totale 297
Nome #
Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis 49
Location of first attack predicts the site of subsequent relapses in multiple sclerosis 48
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion 47
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 45
Copper deficiency-associated myelopathy in cryptogenic hyperzincemia: A case report 45
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary? 43
The real-world effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An Italian multicentre study 40
Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey 39
Successful intravenous immunoglobulin treatment in relapsing MOG-antibody-associated disease 37
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 34
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing–remitting multiple sclerosis 30
Totale 457
Categoria #
all - tutte 2.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202066 0 0 0 0 0 0 14 0 2 12 20 18
2020/202122 1 3 1 3 2 1 0 1 5 1 2 2
2021/202260 0 2 2 4 3 1 8 2 0 7 3 28
2022/2023158 19 12 18 7 0 15 0 8 74 0 5 0
2023/202475 3 9 2 2 4 18 1 1 7 11 7 10
2024/202576 2 12 26 10 25 1 0 0 0 0 0 0
Totale 457